_1777352142843_145525226.png&w=48&q=75){kind=small}
_1777352244987_250242181.png&w=48&q=75){kind=small}
Drug Authority Withdraws Six Chlorodiazepoxide Drugs
The Egyptian Medicines Authority issued a decision to withdraw 6 medications containing the substance chlorodiazepoxide from the market, instructing the concerned company to return any remaining stock by August 20, 2026. This action is part of ongoing efforts to monitor medication availability and ensure the safety of pharmaceuticals in circulation. The withdrawn drugs include products such as CLOXIDE, DIBREX, COLOVERIN A, LIBRAX, CLIDIASPASM, and EPIRAX. The quantities have been documented in accordance with standard procedures, with an emphasis on adhering to the instructions. This step was taken based on directives from the Head of the Medicines Authority, aimed at safeguarding consumers and overseeing the pharmaceutical market.
Notice: This Is an AI-Generated Summary
Comments (0)